Description

I help biotech, pharma, and diagnostics teams turn complex microbiology evidence into clear, go/no-go decisions. PhD microbiologist and former team lead (BIOASTER) with Medical Affairs experience, I specialise in biofilms, AMR, phages, antifungals, and the skin/mucosal microbiome. I bridge R&D ↔ business: aligning science, stakeholders, and timelines so projects de-risk faster and communicate better.

What you get

• Decision-ready briefs: ranked insights from literature & clinical trials + risks/next steps

• R&D strategy: model/screen selection (incl. biofilm), protocol critique, success criteria

• Diagnostics & claims: evidence mapping, substantiation, publication planning

• Competitive landscapes: pipelines, mechanisms, trials, KOLs, whitespace

• Executive storytelling: slide docs, congress coverage, messaging for MA/BD

How I work

Structured, fast, and pragmatic. I build lightweight AI/data workflows (PubMed/CT mining, trend tracking, basic analytics) to save time without black-box hype. Clear deliverables (slides/Word dashboards), regular check-ins, and sharp recommendations you can act on tomorrow. Remote EU/UK; on-site by request; NDA-friendly.

Keywords: microbiology, biofilms, antimicrobial resistance, phage therapy, antifungals, diagnostics, medical affairs, evidence generation, scientific communication, clinical trials, strategy, AI/data.

Domaines d’expertise

Langues

Polonais
Bilingue ou natif
Anglais
Capacité professionnelle complète
Néerlandais
Capacité professionnelle limitée

Préférences en matière de lieu de travail

Accepte de travailler sur site

Lyon (jusqu’à 50 km)

MicroBioBridge Consulting
Founder & Life Science Consultant
BIOTECHNOLOGIES
février 2025 - Aujourd'hui (1 an et 4 mois)
Lyon, France
• Providing freelance scientific support in microbiology, medical affairs, and life sciences communication.
Microbiology Research Communication strategy Needs analysis Corporate strategy
BIOASTER
Team Leader Microbiology
décembre 2019 - août 2024 (4 ans et 8 mois)
Lyon, France
• Led cross-functional R&D teams in diagnostics, microbiota, and infectious diseases, managed collaborations with pharma, biotech, and research institutes.
• Development of BIOFILM-ID (biofilm profiling toolkit) and centralized Bacterial Strain Collection for industrial partnerships.
• Co-developed AI-powered platforms (HoloMoA, MetSaMoA, BIND-IT) for antibiotic mode-of-action prediction and molecular profiling including early-stage VHH-discovery workflow.
• Contributed to the strategic development of VHH discovery workflows by integrating display technologies, NGS, and structural modeling.
• Contributed scientific input to internal decision-making and stakeholder communications.
• Built strategic partnerships and drove co-development of microbiology solutions with external stakeholders.
• Mentored 3 scientists and students; aligned execution with key R&D milestones.
• Oversaw complex projects from concept to delivery under ISO 9001 and IVDR compliance.
• Keynote speaker at ESVB 2021 on biofilm innovation and translational research.
BIOASTER
Interim Manager of Microbiology Technological Unit
BIOTECHNOLOGIES
janvier 2022 - juin 2022 (5 mois)
Lyon, France
• Directed 20 FTEs, aligning microbiology and preclinical operations with strategic goals.
• Led pharma collaborations to advance microbiology-based technologies toward commercialization.
• Secured ISO 9001 accreditation through quality system optimization and regulatory readiness.